Dr. Reddy's Ltd. has become a global player within the American, Asian and European pharmaceutical markets over the last 30 years, having started as a small pharmaceutical ingredients supplier in 1984. This success was due to three key factors: a strong corporate governance, long term thinking and innovativeness, and control of the entire value chain. The advantage gained through R&D will be the main driving factor for the company to increase its market share within the next few years and to develop new long-term strategies. Company acquisitions and local production in key markets such as Europe, Russia, and emerging markets enhance the supply chain by being continuously able to strengthen and expand to new pharmaceutical markets in a growing number of countries. Good relations with governments, the willingness and understanding to open up foreign manufacturing plants, and not only importing products but strengthening different countries' economies, make Dr. Reddy's a reputable company which will show much more of its potential within the next years.
CITATION STYLE
Egender, M., & Rotari, I. (2016). Dr. Reddy’s: A case study on conquering the world with affordable medicine for the masses. In Multinational Management: A Casebook on Asia’s Global Market Leaders (pp. 133–147). Springer International Publishing. https://doi.org/10.1007/978-3-319-23012-2_8
Mendeley helps you to discover research relevant for your work.